目前业务管道8PPK要涵盖两大临OhE4阶段药物开发tKZk目,分别为GDC-0084和TRX-E-002-1(Cantrixil),后者为具Cu1n抗癌活性的第mkX3代苯并吡喃分tHSn,或将用于治WiwZ卵巢癌pBR0
GolfTeamInvitationalTournament